Biology:Epoetin theta
| Clinical data | |
|---|---|
| Trade names | Biopoin, Eporatio |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem SID | |
| DrugBank | |
| UNII | |
| Chemical and physical data | |
| Formula | C815H1317N233O241S5 |
| Molar mass | 18396.19 g·mol−1 |
Epoetin theta, sold under the brand name Biopoin among others, is a form of the human hormone erythropoietin produced using recombinant DNA technology.[1][2]
It acts as a short acting erythropoiesis-stimulating agent (ESA) for the treatment of anemia associated with chronic kidney disease and chemotherapy-induced anemia in patients with cancer.[3]
Medical uses
Epoetin theta is indicated for the treatment of symptomatic anemia in adults.[1]
Side effects
The most common side effects include shunt thrombosis (clots that can form in blood vessels of patients on dialysis, a blood clearance technique), headache, hypertension (high blood pressure), hypertensive crisis (sudden, dangerously high blood pressure), skin reactions, arthralgia (joint pain) and influenza (flu)-like illness.[1] Epoetin theta was authorized for medical use in the European Union in October 2009.[1] It is on the World Health Organization's List of Essential Medicines.[4]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Biopoin EPAR". 16 December 2009. https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ↑ 2.0 2.1 "Eporatio EPAR". 16 December 2009. https://www.ema.europa.eu/en/medicines/human/EPAR/eporatio. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ↑ "Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review". Clinical Therapeutics 36 (4): 594–610. April 2014. doi:10.1016/j.clinthera.2014.02.007. PMID 24656152.
- ↑ World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. WHO/MHP/HPS/EML/2021.02.
attribution contains material copied from Biopoin | European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin 2021
External links
- "Epoetin theta". Drug Information Portal. U.S. National Library of Medicine. https://druginfo.nlm.nih.gov/drugportal/rn/762263-14-9.
 |  |
